The Lung Cancer Sessions: highlights from IASLC WCLC

VJOncology has assembled an international panel of leading experts in lung cancer and mesothelioma to bring you the key highlights from the IASLC World Conference on Lung Cancer (WCLC), which was held virtually in January 2021. Daniel Tan (National Cancer Centre Singapore, Singapore) is joined by Melissa Johnson (Sarah Cannon Research Institute, TN) and Dean Fennell (University Hospitals of Leicester NHS Trust, UK), who offer their perspectives on the exciting data and what research could change practice in the future. Tune in to this podcast to learn about the latest advances in KRAS G12C inhibitors, antibody-drug conjugates and anti-TIGIT antibodies, as well as the most promising neoadjuvant therapeutic strategies being studied. The panel also consider the use of biomarkers for evaluating response to immunotherapy, the importance of lung cancer screening programs and more.